ABBV vs AMGN
AbbVie (ABBV) and Amgen (AMGN) compared side by side. AbbVie (ABBV) is larger, with a market cap of $504.8B versus $237.5B for Amgen, about 2.1 times the size. On trailing earnings, AMGN is cheaper at 27.3x versus 80.7x for ABBV.
Head to head
| Metric | ABBV | AMGN |
|---|---|---|
| Market cap | $504.8B | $237.5B |
| P/E (TTM) | 80.7x | 27.3x |
| Forward P/E | 17.6x | 17.9x |
| Revenue (TTM) | $64.4B | $38.1B |
| Revenue growth | 10.2% | 9.5% |
| Gross margin | 72.8% | 71.9% |
| Operating margin | 40.0% | 35.5% |
| Free cash flow | $18.2B | $10.2B |
| Dividend yield | 2.42% | 2.29% |
| 1-year return | +28.9% | +54.1% |
| 5-year return (annual) | +25.6% | +19.7% |
| Max drawdown | -45% | -78% |
| FI Handbook grade | B | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$10.0K
$15.0K
$20.0K
$25.0K
20222023202420252026
ABBV vs AMGN FAQ
Which is bigger, ABBV or AMGN?
AbbVie (ABBV) is larger, with a market cap of $504.8B versus $237.5B for Amgen, about 2.1 times the size.
Is ABBV or AMGN cheaper?
On trailing earnings, AMGN is cheaper at 27.3x versus 80.7x for ABBV. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABBV or AMGN?
AMGN returned +54.1% over the past year including dividends, versus +28.9% for ABBV, through October 23, 2026.
Which pays a higher dividend, ABBV or AMGN?
ABBV yields 2.42% versus 2.29% for AMGN.